서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 5,001 to 5,020 of 7,786

Issue DateTitle / Author(s) / CitationFileAltmetrics
2022-01
Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival
DOI
2018-02
Radiosensitization by a novel DNMT Inhibitor, MA 17 and its mechanism in vitro
view file
2019-08
Radiosensitization of Glioblastoma Cells by a Novel DNA Methyltransferase-Inhibiting Phthalimido-Alkanamide Derivative
view filelink
2011-07
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial
DOI
2022-04
Radiotherapy versus Surgery in Early-Stage HPV-Positive Oropharyngeal Cancer
DOI
1961-06
RAI에 대한 갑상선 흡수율 증진에 관한 연구

진병호; 황준식

Seoul J Med, Vol.2 No.1, pp. 23-28

view file
2002-05
Ramosetron for the prevention of cisplatin-induced acute emesis: A prospective randomized comparison with granisetron

Kang, YK; Park, YH; Ryoo, BY; Bang, YJ; Cho, KS; Shin, DB; Kim, HC; Lee, KH; Park, YS; Lee, KS; Heo, DS; Kim, SY; Cho, EK; Lim, HY; Kim, WK; Lee, JA; Kim, TY; Lee, JC; Yoon, HJ; Kim, NK

Journal of International Medical Research, Vol.30 No.3, pp.220-229

DOI
2009-02
Ramosetron for the Prevention of Nausea and Vomiting During 5-Fluorouracil-Based Chemoradiotherapy for Pancreatico-biliary Cancer

Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

Japanese Journal of Clinical Oncology, Vol.39 No.2, pp.111-115

DOI
2020-09
Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)
DOI
2019-12
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2+metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)
DOI
2008-07
Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan clinical oncology group study JCOG 0705 and korea gastric cancer association study KGCA01
DOI
2019-01
Randomized Open Labe Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
DOI
2019-01
Randomized phase III trial of irinotecan plus cisplatin versus etoposide plus cisplatin in chemotherapy-naïve Korean patients with extensive-disease small cell lung cancer
view fileDOI
2017-09
Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy
DOI
2023-05
Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis
DOI
2015-11
Randomized, double-blind phase II trial with prospective classification by ATM protein level to evaluate the efficacy and tolerability of olaparib plus paclitaxel in patients with recurrent or metastatic gastric cancer
DOI
2022-09
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel +/- Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
DOI
2017-01
Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NF kappa B pathways in autophagy- and p62-dependent manners

Ko, Jung Hwa; Yoon, Sun-Ok; Lee, Hyun Ju; Oh, Joo Youn

Oncotarget, Vol.8 No.25, pp.40817-40831

DOI
2010-12
Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (Crizotinib, PF02341066) in an ALK Translocation-Positive Patient with Non-small Cell Lung Cancer
DOI
2015-10
Rapid Hepatobiliary Excretion of Micelle-Encapsulated/Radiolabeled Upconverting Nanoparticles as an Integrated Form
view fileDOI
1250 251 252 253 254 255 256390